Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by PÄLVE, H.
Right arrow Articles by KANTO, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PÄLVE, H.
Right arrow Articles by KANTO, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1995, Vol. 74, No. 6 704-705
© 1995 The Board of Management and Trustees of the British Journal of Anaesthesia

other

Maximum recommended doses of lignocaine are not toxic

H. PÄLVE, MD, O. KIRVELÄ, MD, H. OLIN, MD, E. SYVÄLAHTI, MD and J. KANTO, MD

Department of Anaesthesiology, Turku University Hospital SF-20520 Turku, Finland
Department of Pharmacology, Turku University Hospital SF-20520 Turku, Finland

The maximum recommended doses of lignocaine are frequently exceeded in clinical practice as some blocks may need more lignocaine to produce adequate anaesthesia. We have examined the success rate of brachial plexus block, possible toxic symptoms after a dose of lignocaine 900 mg with adrenaline, and the maximum plasma concentration of lignocaine produced in 17 adult patients. In all patients, the block was excellent and no toxic symptoms were encountered. The highest mean lignocaine plasma concentration was 2.9 µg ml–1 45 min after the block. We conclude that in brachial plexus block, the dose of lignocaine with adrenaline can be as high as 900 mg without fear of toxic symptoms


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Ultrasound MedHome page
N. S. Sandhu, C. S. Bahniwal, and L. M. Capan
Feasibility of an Infraclavicular Block With a Reduced Volume of Lidocaine With Sonographic Guidance
J. Ultrasound Med., January 1, 2006; 25(1): 51 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
N. S. Sandhu and L. M. Capan
Ultrasound-guided infraclavicular brachial plexus block
Br. J. Anaesth., August 1, 2002; 89(2): 254 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. H. Y. Ng, O. S. Tang, D. K. C. Chui, and P. C. Ho
Comparison of two different doses of lignocaine used in paracervical block during oocyte collection in an IVF programme
Hum. Reprod., October 1, 2000; 15(10): 2148 - 2151.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
U.I.O. Ezeh, S. Shepherd, H.D.M. Moore, and I.D. Cooke
Morbidity and cost-effectiveness analysis of outpatient analgesia versus general anaesthesia for testicular sperm extraction in men with azoospermia due to defects in spermatogenesis
Hum. Reprod., February 1, 1999; 14(2): 321 - 328.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.